GBP5 and neoplasm: The 5‐year survival rates were 100.0% in the GBP5 tumor (T) Low and GBP5 stroma (S) High group; followed by GBP5 (T) High and GBP5 (S) High group (80.8%); GBP (T) High and GBP5 (S) Low group (75.0%); and GBP5 (T) Low and GBP5 (S) Low group (67.1%).